Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Germline variants in IKZF1, ARID5B, and CEBPE as risk factors for adult-onset acute lymphoblastic leukemia: an analysis from the GMALL study group.

Literature DB >> 24497567

Germline variants in IKZF1, ARID5B, and CEBPE as risk factors for adult-onset acute lymphoblastic leukemia: an analysis from the GMALL study group.

Thomas Burmeister¹, Gesine Bartels, Daniela Gröger, Heiko Trautmann, Stefan Schwartz, Klaus Lenz, Carola Tietze-Bürger, Andreas Viardot, Ralph Wäsch, Heinz-August Horst, Richard Reinhardt, Nicola Gökbuget, Dieter Hoelzer, Michael Kneba, Monika Brüggemann.
1. thomas.burmeister@charite.de.

Abstract

Entities: Disease Gene

Keywords: ARID5B; CEBPE; IKFZ1; acute lymphoblastic leukemia; adult-onset; germline variants; risk factors

Mesh：

Substances：

Year: 2014 PMID： 24497567 PMCID： PMC3912981 DOI： 10.3324/haematol.2013.090720

Source DB: PubMed Journal: Haematologica ISSN： 0390-6078 Impact factor: 9.941

× No keyword cloud information.

14 in total

1. Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk.

Authors: Amy L Sherborne; Fay J Hosking; Rashmi B Prasad; Rajiv Kumar; Rolf Koehler; Jayaram Vijayakrishnan; Elli Papaemmanuil; Claus R Bartram; Martin Stanulla; Martin Schrappe; Andreas Gast; Sara E Dobbins; Yussanne Ma; Eamonn Sheridan; Malcolm Taylor; Sally E Kinsey; Tracey Lightfoot; Eve Roman; Julie A E Irving; James M Allan; Anthony V Moorman; Christine J Harrison; Ian P Tomlinson; Sue Richards; Martin Zimmermann; Csaba Szalai; Agnes F Semsei; Daniel J Erdelyi; Maja Krajinovic; Daniel Sinnett; Jasmine Healy; Anna Gonzalez Neira; Norihiko Kawamata; Seishi Ogawa; H Phillip Koeffler; Kari Hemminki; Mel Greaves; Richard S Houlston
Journal: Nat Genet Date: 2010-05-09 Impact factor: 38.330

2. Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia.

Authors: Monika Brüggemann; Thorsten Raff; Thomas Flohr; Nicola Gökbuget; Makoto Nakao; Jo Droese; Silke Lüschen; Christiane Pott; Matthias Ritgen; Urban Scheuring; Heinz-August Horst; Eckhard Thiel; Dieter Hoelzer; Claus R Bartram; Michael Kneba
Journal: Blood Date: 2005-09-29 Impact factor: 22.113

3. ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia.

Authors: Heng Xu; Cheng Cheng; Meenakshi Devidas; Deqing Pei; Yiping Fan; Wenjian Yang; Geoff Neale; Paul Scheet; Esteban G Burchard; Dara G Torgerson; Celeste Eng; Michael Dean; Frederico Antillon; Naomi J Winick; Paul L Martin; Cheryl L Willman; Bruce M Camitta; Gregory H Reaman; William L Carroll; Mignon Loh; William E Evans; Ching-Hon Pui; Stephen P Hunger; Mary V Relling; Jun J Yang
Journal: J Clin Oncol Date: 2012-01-30 Impact factor: 44.544

Review 4. Rationale for an international consortium to study inherited genetic susceptibility to childhood acute lymphoblastic leukemia.

Authors: Amy L Sherborne; Kari Hemminki; Rajiv Kumar; Claus R Bartram; Martin Stanulla; Martin Schrappe; Eleni Petridou; Agnes F Semsei; Csaba Szalai; Daniel Sinnett; Maja Krajinovic; Jasmine Healy; Marina Lanciotti; Carlo Dufour; Stefania Indaco; Eman A El-Ghouroury; Ruchchadol Sawangpanich; Suradej Hongeng; Samart Pakakasama; Anna Gonzalez-Neira; Evelia L Ugarte; Valeria P Leal; Juan P M Espinoza; Azza M Kamel; Gamal T A Ebid; Eman R Radwan; Serap Yalin; Erdinc Yalin; Mehmet Berkoz; Jill Simpson; Eve Roman; Tracy Lightfoot; Fay J Hosking; Jayaram Vijayakrishnan; Mel Greaves; Richard S Houlston
Journal: Haematologica Date: 2011-04-01 Impact factor: 9.941

5. Genetic polymorphisms in ARID5B, CEBPE, IKZF1 and CDKN2A in relation with risk of acute lymphoblastic leukaemia in adults: a Group for Research on Adult Acute Lymphoblastic Leukaemia (GRAALL) study.

Authors: Pauline Peyrouze; Soizic Guihard; Nathalie Grardel; Céline Berthon; Nicolas Pottier; Arnaud Pigneux; Jean-Yves Cahn; Marie Christine Béné; Véronique Lhéritier; Eric Delabesse; Elizabeth Macintyre; Xavier Thomas; Hervé Dombret; Norbert Ifrah; Meyling Cheok
Journal: Br J Haematol Date: 2012-09-27 Impact factor: 6.998

6. Folate metabolic gene polymorphisms and childhood acute lymphoblastic leukemia: a case-control study.

Authors: A Gast; J L Bermejo; T Flohr; M Stanulla; B Burwinkel; M Schrappe; C R Bartram; K Hemminki; R Kumar
Journal: Leukemia Date: 2006-11-30 Impact factor: 11.528

7. The MLL recombinome of adult CD10-negative B-cell precursor acute lymphoblastic leukemia: results from the GMALL study group.

Authors: Thomas Burmeister; Claus Meyer; Stefan Schwartz; Julia Hofmann; Mara Molkentin; Eric Kowarz; Björn Schneider; Thorsten Raff; Richard Reinhardt; Nicola Gökbuget; Dieter Hoelzer; Eckhard Thiel; Rolf Marschalek
Journal: Blood Date: 2009-01-14 Impact factor: 22.113

8. PHF6 mutations in T-cell acute lymphoblastic leukemia.

Authors: Pieter Van Vlierberghe; Teresa Palomero; Hossein Khiabanian; Joni Van der Meulen; Mireia Castillo; Nadine Van Roy; Barbara De Moerloose; Jan Philippé; Sara González-García; María L Toribio; Tom Taghon; Linda Zuurbier; Barbara Cauwelier; Christine J Harrison; Claire Schwab; Markus Pisecker; Sabine Strehl; Anton W Langerak; Jozef Gecz; Edwin Sonneveld; Rob Pieters; Elisabeth Paietta; Jacob M Rowe; Peter H Wiernik; Yves Benoit; Jean Soulier; Bruce Poppe; Xiaopan Yao; Carlos Cordon-Cardo; Jules Meijerink; Raul Rabadan; Frank Speleman; Adolfo Ferrando
Journal: Nat Genet Date: 2010-03-14 Impact factor: 38.330

9. Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood.

Authors: Rashmi B Prasad; Fay J Hosking; Jayaram Vijayakrishnan; Elli Papaemmanuil; Rolf Koehler; Mel Greaves; Eamonn Sheridan; Andreas Gast; Sally E Kinsey; Tracy Lightfoot; Eve Roman; Malcolm Taylor; Kathy Pritchard-Jones; Martin Stanulla; Martin Schrappe; Claus R Bartram; Richard S Houlston; Rajiv Kumar; Kari Hemminki
Journal: Blood Date: 2009-12-30 Impact factor: 22.113

10. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.

Authors:
Journal: Nature Date: 2007-06-07 Impact factor: 49.962

7 in total

1. Loss-of-function but not dominant-negative intragenic IKZF1 deletions are associated with an adverse prognosis in adult BCR-ABL-negative acute lymphoblastic leukemia.

Authors: Benjamin Kobitzsch; Nicola Gökbuget; Stefan Schwartz; Richard Reinhardt; Monika Brüggemann; Andreas Viardot; Ralph Wäsch; Michael Starck; Eckhard Thiel; Dieter Hoelzer; Thomas Burmeister
Journal: Haematologica Date: 2017-07-27 Impact factor: 9.941

Germline variants in IKZF1, ARID5B, and CEBPE as risk factors for adult-onset acute lymphoblastic leukemia: an analysis from the GMALL study group.

1. Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk.

2. Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia.

3. ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia.

Review 4. Rationale for an international consortium to study inherited genetic susceptibility to childhood acute lymphoblastic leukemia.

5. Genetic polymorphisms in ARID5B, CEBPE, IKZF1 and CDKN2A in relation with risk of acute lymphoblastic leukaemia in adults: a Group for Research on Adult Acute Lymphoblastic Leukaemia (GRAALL) study.

6. Folate metabolic gene polymorphisms and childhood acute lymphoblastic leukemia: a case-control study.

7. The MLL recombinome of adult CD10-negative B-cell precursor acute lymphoblastic leukemia: results from the GMALL study group.

8. PHF6 mutations in T-cell acute lymphoblastic leukemia.

9. Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood.

10. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.

1. Loss-of-function but not dominant-negative intragenic IKZF1 deletions are associated with an adverse prognosis in adult BCR-ABL-negative acute lymphoblastic leukemia.

Review 2. The Role of ARID5B in Acute Lymphoblastic Leukemia and Beyond.

3. Aberrant ARID5B expression and its association with Ikaros dysfunction in acute lymphoblastic leukemia.

Review 4. Association of the independent polymorphisms in CDKN2A with susceptibility of acute lymphoblastic leukemia.

5. A common genetic variation in CEBPE and acute lymphoblastic leukemia: a meta-analysis of the available evidence.

Review 6. Transcriptional Regulation of Genes by Ikaros Tumor Suppressor in Acute Lymphoblastic Leukemia.

7. Validations of Top and Novel Susceptibility Variants in All-Age Chinese Patients With Acute Lymphoblastic Leukemia.